Turner N - Search Results

1

Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.

Hrebien S, Citi V, Garcia-Murillas I, Cutts R, Fenwick K, Kozarewa I, McEwen R, Ratnayake J, Maudsley R, Carr TH, de Bruin EC, Schiavon G, Oliveira M, Turner N. Hrebien S, et al. Among authors: turner n. Ann Oncol. 2019 Jun 1;30(6):945-952. doi: 10.1093/annonc/mdz085. Ann Oncol. 2019. PMID: 30860573 Free PMC article.

2

FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas.

Reis-Filho JS, Simpson PT, Turner NC, Lambros MB, Jones C, Mackay A, Grigoriadis A, Sarrio D, Savage K, Dexter T, Iravani M, Fenwick K, Weber B, Hardisson D, Schmitt FC, Palacios J, Lakhani SR, Ashworth A. Reis-Filho JS, et al. Clin Cancer Res. 2006 Nov 15;12(22):6652-62. doi: 10.1158/1078-0432.CCR-06-1164. Clin Cancer Res. 2006. PMID: 17121884

3

Integrated functional, gene expression and genomic analysis for the identification of cancer targets.

Iorns E, Lord CJ, Grigoriadis A, McDonald S, Fenwick K, Mackay A, Mein CA, Natrajan R, Savage K, Tamber N, Reis-Filho JS, Turner NC, Ashworth A. Iorns E, et al. Among authors: turner nc. PLoS One. 2009;4(4):e5120. doi: 10.1371/journal.pone.0005120. Epub 2009 Apr 9. PLoS One. 2009. PMID: 19357772 Free PMC article.

4

Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1.

Aarts M, Sharpe R, Garcia-Murillas I, Gevensleben H, Hurd MS, Shumway SD, Toniatti C, Ashworth A, Turner NC. Aarts M, et al. Cancer Discov. 2012 Jun;2(6):524-39. doi: 10.1158/2159-8290.CD-11-0320. Epub 2012 Apr 23. Cancer Discov. 2012. PMID: 22628408 Free article.

5

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, Van de Vijver M, Viale G, Loi S, Reis-Filho JS. Guiu S, et al. Among authors: turner n. Ann Oncol. 2012 Dec;23(12):2997-3006. doi: 10.1093/annonc/mds586. Ann Oncol. 2012. PMID: 23166150 Free article. Review.

6

Noninvasive detection of HER2 amplification with plasma DNA digital PCR.

Gevensleben H, Garcia-Murillas I, Graeser MK, Schiavon G, Osin P, Parton M, Smith IE, Ashworth A, Turner NC. Gevensleben H, et al. Clin Cancer Res. 2013 Jun 15;19(12):3276-84. doi: 10.1158/1078-0432.CCR-12-3768. Epub 2013 May 1. Clin Cancer Res. 2013. PMID: 23637122 Free PMC article.

7

An siRNA screen identifies the GNAS locus as a driver in 20q amplified breast cancer.

Garcia-Murillas I, Sharpe R, Pearson A, Campbell J, Natrajan R, Ashworth A, Turner NC. Garcia-Murillas I, et al. Among authors: turner nc. Oncogene. 2014 May 8;33(19):2478-86. doi: 10.1038/onc.2013.202. Epub 2013 Jun 10. Oncogene. 2014. PMID: 23752180 Free PMC article.

8

Determination of HER2 amplification status on tumour DNA by digital PCR.

Garcia-Murillas I, Lambros M, Turner NC. Garcia-Murillas I, et al. PLoS One. 2013 Dec 26;8(12):e83409. doi: 10.1371/journal.pone.0083409. eCollection 2013. PLoS One. 2013. PMID: 24386193 Free PMC article.

9

An update on the medical management of breast cancer.

Yeo B, Turner NC, Jones A. Yeo B, et al. BMJ. 2014 Jun 9;348:g3608. doi: 10.1136/bmj.g3608. BMJ. 2014. PMID: 24912480 Review. No abstract available.

10

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

Turner NC, Ro J, André F, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Huang Bartlett C, Zhang K, Giorgetti C, Randolph S, Koehler M, Cristofanilli M; PALOMA3 Study Group. Turner NC, et al. N Engl J Med. 2015 Jul 16;373(3):209-19. doi: 10.1056/NEJMoa1505270. Epub 2015 Jun 1. N Engl J Med. 2015. PMID: 26030518 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,876 results

Search Page